Singapore markets close in 4 hours 19 minutes
  • Straits Times Index

    3,249.49
    -2.88 (-0.09%)
     
  • Nikkei

    27,732.84
    -153.03 (-0.55%)
     
  • Hang Seng

    19,469.46
    +28.28 (+0.15%)
     
  • FTSE 100

    7,521.39
    -46.15 (-0.61%)
     
  • BTC-USD

    17,030.30
    +27.82 (+0.16%)
     
  • CMC Crypto 200

    402.01
    +0.21 (+0.05%)
     
  • S&P 500

    3,941.26
    -57.58 (-1.44%)
     
  • Dow

    33,596.34
    -350.76 (-1.03%)
     
  • Nasdaq

    11,014.89
    -225.05 (-2.00%)
     
  • Gold

    1,783.80
    +1.40 (+0.08%)
     
  • Crude Oil

    74.27
    +0.02 (+0.03%)
     
  • 10-Yr Bond

    3.5130
    -0.0860 (-2.39%)
     
  • FTSE Bursa Malaysia

    1,477.18
    +5.63 (+0.38%)
     
  • Jakarta Composite Index

    6,825.09
    -67.48 (-0.98%)
     
  • PSE Index

    6,649.08
    -25.30 (-0.38%)
     

Which Growth Stock Is a Better Buy Right Now -- AbbVie or InMode?

The popularity of cosmetic procedures is unquestionably on the rise. Major pharmaceutical AbbVie (NYSE: ABBV) is plagued by concerns about the impending patent cliff on its top-selling drug. At the same time, healthcare equipment provider InMode (NASDAQ: INMD) has been punished by Wall Street's current skepticism about growth stocks.